[go: up one dir, main page]

UY31535A1 - Método para diagnosticar tumores colorrectales - Google Patents

Método para diagnosticar tumores colorrectales

Info

Publication number
UY31535A1
UY31535A1 UY31535A UY31535A UY31535A1 UY 31535 A1 UY31535 A1 UY 31535A1 UY 31535 A UY31535 A UY 31535A UY 31535 A UY31535 A UY 31535A UY 31535 A1 UY31535 A1 UY 31535A1
Authority
UY
Uruguay
Prior art keywords
tumors
colorectural
diagnosing
prognosis
diagnosis
Prior art date
Application number
UY31535A
Other languages
English (en)
Inventor
Gabriel Capella Munar
Simo Schwartz Navarro
Cristina Alemany Boor
Xavier Gregori
Olga Durany Toerk
Elisabet Roselli Vives
Tamara Maes
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of UY31535A1 publication Critical patent/UY31535A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57419—Specifically defined cancers of colon
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La presente invencion se refiere a método de diagnostico y/o pronostico de tumores colorrectales que comprende analizar una muestra obtenida de un paciente para determinar el nivel de expresion del gen TNFRSF12A.
UY31535A 2007-12-14 2008-12-15 Método para diagnosticar tumores colorrectales UY31535A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200703334 2007-12-14

Publications (1)

Publication Number Publication Date
UY31535A1 true UY31535A1 (es) 2009-03-31

Family

ID=40456727

Family Applications (1)

Application Number Title Priority Date Filing Date
UY31535A UY31535A1 (es) 2007-12-14 2008-12-15 Método para diagnosticar tumores colorrectales

Country Status (3)

Country Link
AR (1) AR069697A1 (es)
UY (1) UY31535A1 (es)
WO (1) WO2009077157A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2017159739A1 (ja) * 2016-03-16 2019-01-31 学校法人同志社 抗がん剤
CN118506863A (zh) * 2024-05-11 2024-08-16 青岛可立生物医药有限公司 一种结直肠癌诊断及分型的设备、系统
CN118522437A (zh) * 2024-05-11 2024-08-20 青岛可立生物医药有限公司 一种结直肠癌的预测方法、系统和设备

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7118912B2 (en) * 2002-08-26 2006-10-10 Case Western Reserve University Methods and compositions for categorizing patients
CA2496781A1 (en) * 2002-08-26 2004-03-04 Case Western Reserve University Methods for treating patients and identifying therapeutics
US20070099209A1 (en) * 2005-06-13 2007-05-03 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing cancer

Also Published As

Publication number Publication date
WO2009077157A1 (en) 2009-06-25
AR069697A1 (es) 2010-02-10

Similar Documents

Publication Publication Date Title
MY195999A (en) Molecular Detection/Diagnosis Reagent for Tumor
BR112014030750A2 (pt) Método para diagnóstico, prognóstico e tratamento da metástase do câncer pulmonar
WO2014140933A3 (en) Method for the prognosis and treatment of cancer metastasis
MX2013003880A (es) Metodo para diagnostico, pronostico y tratamiento de la metastasis de carcer de mama.
ES2572372T3 (es) Método de diagnóstico de enfermedades neurodegenerativas basado en la medición de los niveles o de la actividad de SIRT1
BR112014025269A2 (pt) método para o prognóstico e tratamento de metástase de câncer
CL2007001571A1 (es) Perfil genico indicativo de probabilidad aumentada de que un paciente responda o no a una inmunoterapia; uso de dicho perfil; procedimiento de identificacion del perfil; uso de sonda para identificar la expresion diferencial de al menos un gen de act
AR077026A1 (es) Marcadores de riesgo para enfermedades cardiovasculares
ES2527592T3 (es) Métodos basados en microARN para el diagnóstico del cáncer de colon
WO2012006589A3 (en) Methods and compositions for identification, assessment and treatment of cancers associated with hedgehog signaling
BR112016007864A2 (pt) método para a prognose e tratamento de metástase de câncer
BRPI0920069A8 (pt) Biomarcadores
ATE554389T1 (de) Apex als marker für lungenkrebs
BR112014031414A2 (pt) métodos de detectar doenças ou condições utilizando células doentes circulantes
BR112015008255A2 (pt) método para o diagnóstico, prognóstico e tratamento de metástase de câncer de próstata
HK1133295A1 (en) Use of protein s100a12 as a marker for colorectal cancer s100a12
EA201490946A1 (ru) Способ количественной оценки лечения рака
Leung et al. Ovarian cancer biomarkers: current state and future implications from high-throughput technologies
MX2013005796A (es) Metodos para detectar enfermedades o alteraciones neurodegenerativas.
CA2839777C (en) Methods for the prognostic and/or diagnostic of neurodegenerative disease, methods to identify candidate compounds and compounds for treating neurodegenerative disease
NZ729773A (en) Biomarkers for disease progression in melanoma
MX2016009450A (es) Ensayo novedoso para detectar periostina humana.
MX2015002749A (es) Metodo diagnostico y terapeutico para el cancer dirigido a moleculas expresadas en celulas madre cancerosas.
UY31535A1 (es) Método para diagnosticar tumores colorrectales
WO2014020444A3 (en) Methods and compositions for diagnosis and prognosis in breast cancer

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20180108